Erythromycin or Clindamycin - is it Still an Empirical Therapy against Streptococcus agalactiae in Patients Allergic to Penicillin?-Reference-Cited by-同舟云学术

Erythromycin or Clindamycin - is it Still an Empirical Therapy against Streptococcus agalactiae in Patients Allergic to Penicillin?

Published:2017-06-28 Issue:2 Volume:66 Page:265-268
ISSN:1733-1331
Container-title:Polish Journal of Microbiology
language:
Short-container-title:Pol J Microbiol

Author:

Leszczyński Piotr¹,Sokół-Leszczyńska Beata²,Pietrzak Bronisława³,Sawicka-Grzelak Anna²,Wielgoś Mirosław³

Affiliation:

1. Department of Medical Microbiology, Warsaw Medical University of Warsaw, Warsaw, Poland; Hospital Infection Control Team, Infant Jesus University Hospital, Warsaw, Poland

2. Department of Medical Microbiology, Warsaw Medical University of Warsaw, Warsaw, Poland; Department of Medical Microbiology, Infant Jesus University Hospital, Warsaw, Poland

3. I Department of Obstetrics and Gynecology, Medical University of Warsaw, Warsaw, Poland

Abstract

Retrospective analysis of Streptococcus agalactiae antibiotic susceptibility isolated in 2010 - 2013 was performed. Penicillin was still the first-line antibiotic. Due to the high percentage of strains resistant to erythromycin and clindamycin empirical treatment with these antibiotics may not be effective. Lower resistance rate to erythromycin and clindamycin among strains isolated from infected pregnant women and newborns were observed than among strains isolated from samples from patients hospitalized in other departments (29% and 47% v. 46% and 63%). The increasing resistance rate might give a rise to a new epidemiological situation.

Publisher

Polish Society of Microbiologists

Subject

Microbiology (medical),Applied Microbiology and Biotechnology,General Medicine,Microbiology

Link

https://pjm-microbiology.publisherspanel.com/gicid/pdf/01.3001.0010.7878

Reference19 articles.

1. Abdelazim I.A. 2013. Intrapartum polymerase chain reaction for detection of group B Streptococcus colonisation. Aust. NZJ Obstet. Gynaecol. 53(3):236-242.

2. Arana D.M., B.R. Bezares and C.T. Manrique. 2014. First clinical isolate in Europe of clindamycin-resistant group B Streptococcus mediated by the lnu (B) gene. Rev. Esp. Qui 27(2):106-109.

3. Bigos M., M. Łysakowska and M. Wasiela. 2012. Perinatal infections of etiology Streptococcus agalactiae (in Polish). Post. Mikrobiol. 51(4): 299–308.

4. Brown H.L., H.K. Ahmadzia and R.P. Heine. 2013. GBS Screening: An update on guidelines and methods. http://contemporaryobgyn.modernmedicine.com/contemporary-obgyn/content/tags/bd-geneohm/gbs-screening-update-guidelines-and-methods, 2016.04.18.

5. Church D.L., H. Baxter and T. Lloyd. 2011. Evaluation of the Xpert group B Streptococcus real-time polymerase chain reaction assay compared to StrepB Carrot Broth for the rapid intrapartum detection of group B streptococcus colonization. Diagn. Microbiol. Infect. Dis. 69:460 – 462.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resistance Rates of Streptococcus agalactiae Strains Isolated from Urine Samples to Various Antibiotics;Sağlık Bilimlerinde Değer;2023-09-21